Skip to main content
Springer logoLink to Springer
. 2015 Apr 14;174(10):1299–1304. doi: 10.1007/s00431-015-2536-2

An hour-specific transcutaneous bilirubin nomogram for Mongolian neonates

Moe Akahira-Azuma 1,, Naohiro Yonemoto 2, Rintaro Mori 3, Shinichi Hosokawa 1, Takeji Matsushita 1, Khulan Sukhbat 4, Gerelmaa Nansal 4, Bayasgalantai Bavuusuren 4, Enkhtur Shonkhuuz 4
PMCID: PMC4575357  PMID: 25869495

Abstract

Transcutaneous bilirubin (TcB) nomograms have been developed for different populations. However, the TcB level, rate of rise and peak varies among countries and ethnicities. The aim of this study was to establish an hour-specific TcB nomogram for healthy term and late preterm Mongolian neonates during the first 144 h after birth. A total of 5084 TcB measurements from 1297 healthy neonates (gestational age ≥35 weeks, birth weight ≥2000 g) were obtained from October 2012 to October 2013. All measurements were performed using the Jaundice Meter, the JM-103 at 6 to 144 postnatal hours. Mongolian infants had the following characteristics: 27.1 % were delivered by cesarean section, 17.8 % had a birth weight >4000 g, and >90 % were being breastfed. TcB percentiles for each designated time point were calculated for the development of an hour-specific nomogram. TcB levels increased most rapidly in the first 24 h and less rapidly from 24 to 78 h, reaching a plateau after 78 h for the 50th percentile. TcB levels of Mongolian neonates for each time point were higher than those of previous studies.

Conclusion: The higher values of the TcB nomogram for Mongolian neonates may be due to their Asian ethnicity and exclusive breastfeeding.

What is Known:
• TcB nomograms for neonatal jaundice screening have been established for many countries and ethnicities. The pattern of the TcB nomogram varies by country and ethnicity.
What is New:
• A TcB nomogram for neonates of Mongolian ethnicity at 6–144 postnatal hours was created and it had higher values than those in previous studies.

Keywords: Neonatal hyperbilirubinemia, Transcutaneous bilirubin, Hour-specific nomogram, Mongolian

Introduction

Neonatal hyperbilirubinemia and neurological sequelae resulting from kernicterus pose a serious medical burden in both developing and developed countries [13, 15, 16, 23]. However, severe hyperbilirubinemia in the newborn is preventable through appropriate follow-up, diagnosis, and treatment, such as phototherapy and exchange transfusions [8, 9, 13, 23]. The American Academy of Pediatrics (AAP) recommends that all neonates undergo total serum bilirubin (TSB) or transcutaneous bilirubin (TcB) measurements at least once before hospital discharge to assess their risk of hyperbilirubinemia [2, 17].

TcB nomogram is a useful tool for neonatal hyperbilirubinemia screening [10]. However, the TcB value, rate of rise and peak varies with country and ethnicity [5], suggesting that each country and ethnic group has specific risk factors for hyperbilirubinemia. Few studies on the TcB nomogram have been done for Mongolian neonates in a resource-limiting setting [1].

The aim of this study was to create an hour-specific TcB nomogram for healthy Mongolian neonates, which was achieved by obtaining TcB measurements in the first 144 h after birth.

Methods

Patients

This was a prospective cohort study at the National Center for Maternal and Child Health (NCMCH), a tertiary care hospital in Ulaanbaatar, Mongolia. Neonates who were eligible for enrollment were healthy newborns ≥35 weeks of gestation with a birth weight ≥2000 g who were delivered in the hospital on a weekday (from Monday to Friday morning) and whose address were in the Bayangol district. Exclusion criteria included the following: infants with birth asphyxia, respiratory distress, NICU admission, congenital infection, Rh isoimmunization, jaundice within 24 h of birth, skin infection, congenital spinal anomaly, those with no TcB measurement, and cases with missing information. The study was carried out from October 15, 2012 to October 4, 2013 but was temporarily suspended between June 28 and August 2, 2013 when the maternity unit was closed for renovation. Perinatal information on the mother and infant were extracted from their medical charts including sex, gestational age, birth weight, mode of delivery, duration of hospitalization, maternal age, parity, gravidity, maternal blood type, family history of siblings, and feeding type before and after discharge.

This study was approved by the NCMCH ethics committee in Mongolia and the National Center for Global Health and Medicine (NCGM) human investigation ethics committee in Japan, in accordance with the Declaration of Helsinki. Informed consent was obtained from all individual participants (mothers of the infants) included in the study.

Measurements

TcB measurements were performed between 9 am and 5 pm twice daily (once in the morning and once in evening) from Monday to Friday. The Jaundice Meter JM-103 (Konica Minolta, Osaka, Japan) was used by properly trained pediatricians or a research technician to measure TcB. The operation of the JM-103 and its measurement technique have been described previously [1]. Briefly, TcB levels were measured at the forehead and at the midsternum three times at each site, and the median value was defined as the TcB at each measurement site. The highest value of two sites was used as the TcB for each infant. Because NCMCH applies a discharge policy of ≥48 h for vaginally delivered infants and ≥72 h for those delivered by cesarean section, the parents were advised to return to the outpatient clinic for follow-up measurements. Enrolled neonates returned for a follow-up visit between days 3–6 or earlier if the parents noticed worsening jaundice in their child. Parents who did not bring their child for the visit were reminded by telephone. An enrollment number was given to each neonate and recorded in a log book to identify the study neonate during the visit. TcB values were recorded on a flow sheet designed for the study and attached to the signed informed consent form in the medical record of each infant.

TcB measurements obtained at 6 ± 2 h intervals up to 144 h were examined [12, 18]. TcB measurements not taken between these time measurements were omitted from analysis. The decision regarding the need for phototherapy was made by the attending pediatrician based on TSB levels, in accordance with NCMCH’s protocol and/or AAP guidelines [2]. If TcB values were obtained, measurement values obtained after the initiation of phototherapy were excluded from analysis.

The characteristics of mothers and children are presented as percentages for binary and categorical data, and as means and standard deviations for continuous data. The data analysis was performed by using SPSS 15.0 for Windows (SPSS, Chicago, IL).

TcB percentiles (95th, 90th, 75th, 50th, 25th, 10th, and 5th percentiles) were calculated for each designated time. A TcB nomogram with smoothed percentile curves for the period 6–144 postnatal hours was prepared using Microsoft Excel 2010 (Microsoft, Redmond, WA).

Results

Of 1846 live births in NCMCH during the study period, 549 neonates did not meet the enrollment criteria (Fig. 1), resulting in 1297 healthy term and late-preterm neonates from whom 5084 TcB measurements were obtained. Among these TcB measurements, 3487 that were taken at the designated time were used for analysis. Of the 1297 enrolled neonates, 1137 (87.7 %) returned for the follow-up visit after hospital discharge.

Fig. 1.

Fig. 1

Study flow

Demographic and background data of mothers and neonates are summarized in Table 1. Of note, all neonates were Mongolian, 27.1 % were delivered by a cesarean section, ≥90 % were breastfed, and 17.8 % had a birth weight ≥4000 g. Regarding the family history of jaundice, 851 of 1297 enrolled infants had siblings and 163 of 851 siblings (19.2 %) had a history of treatment for jaundice according to an interview with the mother. Details of the jaundice could not be obtained to clarify the etiology of jaundice.

Table 1.

Characteristics of the enrolled neonates and their mothers

Characteristic n = 1297 (%)
1. Sex Male 662 (51.0)
Female 635 (49.0)
2. Gestational age 35–36 weeks 16 (1.2)
37–40 week 1230 (94.9)
41–42 weeks 51 (3.9)
3. Birth weight 2000–2999 g 92 (7.1)
3000–3999 g 975 (75.1)
4000–4999 g 228 (17.6)
>5000 g 2 (0.2)
4. Mode of delivery Vaginal 945 (72.9)
Cesarean section 352 (27.1)
5. Duration of hospitalization 1–2 day (s) 907 (69.9)
3–4 days 355 (27.4)
5–7 days 35 (2.7)
6. Maternal age 15–24 years old 293 (22.6)
25–34 years old 748 (57.7)
35–45 years old 256 (19.7)
7. Parity 1 320 (24.7)
2 411 (31.7)
3 258 (19.9)
4 169 (13.0)
5 to 9 139 (10.7)
8. Gravidity 1 451 (34.8)
2 541 (41.7)
3 230 (17.7)
4 60 (4.6)
5 to 9 15 (1.2)
9. Maternal blood type O 366 (28.2)
A 347 (26.8)
B 456 (35.2)
AB 116 (8.9)
Unknown 11 (0.8)
No description 1 (0.1)
10. Family history of siblings First baby 446 (34.4)
Phototherapy 161 (12.4)
Exchange transfusion 2 (0.2)
No jaundice 688 (53.0)
11. Feeding (before discharge) Breastfeeding 1264 (97.4)
Formula 3 (0.2)
Mixed 30 (2.3)
12. Feeding (follow-up visit) No follow-up visit 160
Attended follow-up visit 1137
Breastfeeding 1025 (90.1)
Formula 1 (0.1)
Mixed 111 (9.8)

A TcB nomogram with smoothed percentile curves (95th, 90th, 75th, 50th, 25th, 10th, and 5th percentiles) for the time period 6–144 postnatal hours is presented in Fig. 2. The numbers of TcB measurements are shown for each time point. TcB levels increased in a linear fashion most rapidly in the first 24 h and less rapidly from 24 to 78 h, reaching a plateau after 78 h for the 50th percentile.

Fig. 2.

Fig. 2

An hour-specific TcB nomogram for Mongolian neonates with smoothed curves for the 5th, 10th, 25th, 50th, 75th, 90th, and 95th percentiles. Numbers in parentheses indicate the number of TcB measurements at each time point

Discussion

We created an hour-specific TcB nomogram for the first 144 h after birth for Mongolian healthy term and late preterm neonates. The characteristics of this group of Mongolian neonates included delivery by cesarean section in 26.9 % of cases and exclusive breastfeeding in >90 %. The TcB values and rate of rise at each designated time point resulted in a TcB nomogram with higher values than those reported for other countries and ethnicities in previous studies. This result indicates that this group might have risk factors and a higher likelihood of developing neonatal hyperbilirubinemia.

Many TcB nomogram studies have been performed in North America, Europe, and Asia in different groups [3, 6, 7, 11, 12, 14, 18, 19, 21, 25, 28] since the second generation of the TcB meter became available. The risk factors of hyperbilirubinemia were determined to be Asian ethnicity, exclusive breastfeeding, weight loss, and a sibling with neonatal jaundice [17]. In a North American study investigating an hour-specific TcB nomogram in the first 96 h using the JM-103 to measure levels in 3984 neonates, 73.1 % were Caucasian, 45.1 % were delivered by cesarean section, and 66.2 % were breastfed [18]. TcB nomogram for Mongolian neonates showed much higher values than the North American nomogram at each time point. This might be due to the predominant Caucasian ethnicity of the study group [22]. In a study on infants of Asian ethnicity, a TcB nomogram was developed using JM-103 measurements taken from 6035 Chinese infants [28]. These Chinese infants were delivered by cesarean section in 55.5 % of cases, 25.1 % were breastfed, and 9.4 % had a birth weight >4000 g. In contrast, our study of Mongolian neonates showed higher TcB values at each time point, suggesting that exclusive breastfeeding might have contributed to this result [4]. A recent study on the influence of dehydration on body weight loss at 72 h after birth in Taiwan revealed the optimum body weight loss cutoff points for predicting hyperbilirubinemia [27]. Unfortunately, the body weights on each day of TcB measurement were not determined in our study. Therefore, it remains unclear whether the acceleration of hyperbilirubinemia of Mongolian neonates is caused by exclusive breastfeeding itself or by dehydration secondary to inappropriate breastfeeding.

This prospective cohort study was a tertiary hospital-based study that enrolled neonates from one district, and TcB measurements were done either in the maternity unit or in the outpatient clinic [26]. Our study method for creating a TcB nomogram is practical and can be applied in countries with limited resources. This encourages resource-limited countries to create country- and ethnic-specific TcB nomograms.

This study has several limitations. First, there were insufficient numbers of TcB measurements at the follow-up visit on day 3–6, only one to two measurements. Second, the designated times for TcB measurements were difficult to establish, leading to the omission of a certain number of TcB measurements. However, it was impossible to fix a designated TcB measurement time for each neonate in ordinary practice. Third, the glucose-6-phosphate dehydrogenase (G6PD) and direct Coombs test are not routinely performed in prenatal care screening in Mongolia so G6PD deficiency and ABO incompatibility could not be ruled out in this group. Fourth, cephalohematoma, a risk factor for hyperbilirubinemia, might be increased, considering the high percentage of vaginal deliveries and heavy infants (17.8 % had birth weight >4000 g) [20, 24]. Although cephalohematoma should have been identified as a risk factor, this does not affect the validity of the nomogram. Fifth, because infants with significant hyperbilirubinemia were referred to the hospital for further work-up and treatment and were later excluded from the study, the TcB measurements and curves we report here might be lower than the actual TcB values.

The findings in this study contribute to improving appropriate diagnosis and treatment of neonatal hyperbilirubinemia, and might reduce the incidence of neurological impairment in this high-risk ethnic group.

Conclusion

We provide data on TcB levels for the first 144 postnatal hours that were derived from a group of Mongolian term and late preterm neonates. The higher values of the TcB nomogram derived from Mongolian neonates may be due to their Asian ethnicity and exclusive breastfeeding.

Acknowledgments

We thank Dr. Gerentuya Dashzeveg for performing TcB measurements and maternity unit staff for their collaboration in this research project.

Role of the funding source

This work was supported in part by Grants-in-Aid for Research from the National Center for Global Health and Medicine (24A-1, 26A-201 and 27A-1404).

Conflict of interest

The authors declare that they have no conflicts of interest.

Compliance with ethical standards

This study was approved by the National Center for Maternal and Child Health ethics committee in Mongolia and the National Center for Global Health and Medicine human investigation ethics committee in Japan. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. A written informed consent was obtained from all mothers.

Authors’ contributions

MAA conceptualized and designed the study, carried out the initial analyses, drafted the initial manuscript, and approved the final manuscript as submitted. NY conceptualized and advised on the analysis, reviewed the manuscript, and approved the final manuscript as submitted. RM conceptualized and reviewed the manuscript, and approved the final manuscript as submitted. SH, TM reviewed the manuscript, and approved the final manuscript as submitted. KS, GN designed the data collection instruments, coordinated and reviewed the manuscript, and approved the final manuscript as submitted. BB designed the data collection instruments, coordinated and supervised data collection, reviewed the manuscript, and approved the final manuscript as submitted. ES reviewed the manuscript and approved the final manuscript as submitted.

Abbreviations

AAP

American Academy of Pediatrics

G6PD

Glucose-6 pyruvate deficiency

GA

Gestational age

TcB

Transcutaneous bilirubin

TSB

Total serum bilirubin

Contributor Information

Moe Akahira-Azuma, Phone: +81-3-3202-7181, Email: nth3son@yahoo.co.jp.

Naohiro Yonemoto, Email: nyonemoto@gmail.com.

Rintaro Mori, Email: rintaromori@gmail.com.

Shinichi Hosokawa, Email: shosokaw@hosp.ncgm.go.jp.

Takeji Matsushita, Email: tmatsush@hosp.ncgm.go.jp.

Khulan Sukhbat, Email: hulan_1213@yahoo.com.

Gerelmaa Nansal, Email: ngerelmaa@yahoo.com.

Bayasgalantai Bavuusuren, Email: bayasgalantai.b@gmail.com.

Enkhtur Shonkhuuz, Email: enkhtur_mgl@yahoo.com.

References

  • 1.Akahira-Azuma M, Yonemoto N, Ganzorig B, Mori R, Hosokawa S, Matsushita T, Bavuusuren B, Shonkhuuz E. Validation of a transcutaneous bilirubin meter in Mongolian neonates: comparison with total serum bilirubin. BMC Pediatr. 2013;13:151. doi: 10.1186/1471-2431-13-151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.American Academy of Pediatrics Management of hyperbilirubinemia in the newborn infants 35 or more weeks of gestation. Pediatrics. 2004;114:297–316. doi: 10.1542/peds.114.2.506. [DOI] [PubMed] [Google Scholar]
  • 3.Bental YA, Shiff Y, Dorsht N, Litig E, Tuval L, Mimouni FB. Bhutani-based nomograms for the prediction of significant hyperbilirubinaemia using transcutaneous measurements of bilirubin. Acta Paediatr. 2009;98:1902–8. doi: 10.1111/j.1651-2227.2009.01385.x. [DOI] [PubMed] [Google Scholar]
  • 4.Chen YJ, Chen WC, Chen CM. Risk factors for hyperbilirubinemia in breastfed term neonates. Eur J Pediatr. 2012;171:167–171. doi: 10.1007/s00431-011-1512-8. [DOI] [PubMed] [Google Scholar]
  • 5.De Luca D, Jackson GL, Tridente A, Carnielli VP, Engle WD. Transcutaneous bilirubin nomograms: a systematic review of population differences and analysis of bilirubin kinetics. Arch Pediatr Adolesc Med. 2009;163:1054–1059. doi: 10.1001/archpediatrics.2009.187. [DOI] [PubMed] [Google Scholar]
  • 6.De Luca D, Jackson GL, Engle WL. Chapter 5. Transucutaneous bilirubin nomograms. In: De Luca D, Engle WL, Jackson GL, editors. Transcutaneous bilirubinometry. New York: Nova; 2013. pp. 67–89. [Google Scholar]
  • 7.De Luca D, Romagnoli C, Tiberi E, Zuppa AA, Zecca E. Skin bilirubin nomogram for the first 96 h of life in a European normal healthy newborn population, obtained with multiwavelength transcutaneous bilirubinometry. Acta Paediatr. 2008;97:146–50. doi: 10.1111/j.1651-2227.2007.00622.x. [DOI] [PubMed] [Google Scholar]
  • 8.Dennery PA, Seidman D, Stevenson DK. Neonatal hyperbilirubinemia. N Engl J Med. 2001;344:581–590. doi: 10.1056/NEJM200102223440807. [DOI] [PubMed] [Google Scholar]
  • 9.Dijk PH, Hulzebos C. An evidence-based view on hyperbilirubinemia. Acta Paediatr. 2012;101(Suppl 464):3–10. doi: 10.1111/j.1651-2227.2011.02544.x. [DOI] [PubMed] [Google Scholar]
  • 10.Engle WD, Jackson GL, Engle NG. Transcutaneous bilirubinometry. Semin Perinatol. 2014;38:438–451. doi: 10.1053/j.semperi.2014.08.007. [DOI] [PubMed] [Google Scholar]
  • 11.Engle WD, Lai S, Ahmad N, Manning MD, Jackson GL. An hour-specific nomogram for transcutaneous bilirubin values in term and late preterm Hispanic neonates. Am J Perinatol. 2009;26:425–30. doi: 10.1055/s-0029-1214238. [DOI] [PubMed] [Google Scholar]
  • 12.Fouzas S, Mantagou L, Skylogianni E, Mantagos S, Varvarigou A. Transcutaneous bilirubin levels for the first 120 postnatal hours in healthy neonates. Pediatrics. 2010;125:e52–7. doi: 10.1542/peds.2009-0403. [DOI] [PubMed] [Google Scholar]
  • 13.Kaplan M, Bromiker R, Hammerman C. Severe neonatal hyperbilirubinemia and kernicterus: are these still problems in the third millennium? Neonatology. 2011;100:354–362. doi: 10.1159/000330055. [DOI] [PubMed] [Google Scholar]
  • 14.Kuboi T, Kusaka T, Kawada K, Koyano K, Nakamura S, Okubo K, Yasuda S, Isobe K, Itoh S. Hour-specific nomogram for transcutaneous bilirubin in Japanese neonates. Pediatr Int. 2013;55:608–11. doi: 10.1111/ped.12149. [DOI] [PubMed] [Google Scholar]
  • 15.Kuzniewicz MW, Wickremasinghe AC, Wu YW, McCulloch CE, Walsh EM, Wi S, Newman TB. Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns. Pediatrics. 2014;134:504–509. doi: 10.1542/peds.2014-0987. [DOI] [PubMed] [Google Scholar]
  • 16.Lawn JE, Blencowe H, Oza S, You D, Lee AC, Waiswa P, Lalli M, Bhutta Z, Barros AJ, Christian P, Mathers C, Cousens SN, Lancet Every Newborn Study Group Every newborn: progress, priorities, and potential beyond survival. Lancet. 2014;12:189–205. doi: 10.1016/S0140-6736(14)60496-7. [DOI] [PubMed] [Google Scholar]
  • 17.Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant > or =35 weeks’ gestation: an update with clarifications. Pediatrics. 2009;124:1193–8. doi: 10.1542/peds.2009-0329. [DOI] [PubMed] [Google Scholar]
  • 18.Maisels MJ, Kring E. Transcutaneous bilirubin levels in first 96 hours in a normal newborn population of ≥35 weeks gestation. Pediatrics. 2006;117:1169–1173. doi: 10.1542/peds.2005-0744. [DOI] [PubMed] [Google Scholar]
  • 19.Mishra S, Chawla D, Agarwal R, Deorari AK, Paul VK. Transcutaneous bilirubin levels in healthy term and late preterm Indian neonates. Indian J Pediatr. 2010;77:45–50. doi: 10.1007/s12098-010-0007-3. [DOI] [PubMed] [Google Scholar]
  • 20.Ota E, Ganchimeg T, Morisaki N, Vogel JP, Pileggi C, Ortiz-Panozo E, Souza JP, Mori R, WHO Multi-Country Survey on Maternal and Newborn Health Research Network Risk factors and adverse perinatal outcomes among term and preterm infants born small-for-gestational-age: secondary analyses of the WHO Multi-Country Survey on Maternal and Newborn Health. PLoS One. 2014;9:e105155. doi: 10.1371/journal.pone.0105155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Sanpavat S, Nuchprayoon I, Smathakanee C, Hansuebsai R. Nomogram for prediction of the risk of neonatal hyperbilirubinemia, using transcutaneous bilirubin. J Med Assoc Thai. 2005;88:1187–93. [PubMed] [Google Scholar]
  • 22.Setia S, Villaveces A, Dhillon P, Mueller BA. Neonatal jaundice in Asian, white, and mixed-race infants. Arch Pediatr Adolesc Med. 2002;156:276–9. doi: 10.1001/archpedi.156.3.276. [DOI] [PubMed] [Google Scholar]
  • 23.Slusher TM, Zipursky A, Bhutani VK. A global need for affordable neonatal jaundice technologies. Semin Perinatol. 2011;35:185–91. doi: 10.1053/j.semperi.2011.02.014. [DOI] [PubMed] [Google Scholar]
  • 24.Strickland SS (1993) Human nutrition in Mongolia: maternal mortality and rickets. Nomadic Peoples 33:231–239. http://cnp.nonuniv.ox.ac.uk/pdf/NP_journal_back_issues/Human_nutrition_in_Mongolia_S_Strickland.pdf Accessed 7 March 7, 2015
  • 25.Varvarigou A, Fouzas S, Skylogianni E, Mantagou L, Bougioukou D, Mantagos S. Transcutaneous bilirubin nomogram for prediction of significant neonatal hyperbilirubinemia. Pediatrics. 2009;124:1052–9. doi: 10.1542/peds.2008-2322. [DOI] [PubMed] [Google Scholar]
  • 26.Yamamoto LG, Killeen J, French GM. Transcutaneous bilirubin measurement methods in neonates and its utility for Emergency Department use. Pediatr Emer Care. 2012;28:380–384. doi: 10.1097/PEC.0b013e31824dcb43. [DOI] [PubMed] [Google Scholar]
  • 27.Yang WC, Zhao LL, Li YC, Chen CH, Chang YJ, Fu YC, Wu HP. Bodyweight loss in predicting neonatal hyperbilirubinemia 72 hours after birth in term newborn infants. BMC Pediatr. 2013;21;13:145. doi: 10.1186/1471-2431-13-145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Yu ZB, Dong XY, Han SP, Chen YL, Qiu YF, Sha L, Sun Q, Guo XR. Transcutaneous bilirubin nomogram for predicting neonatal hyperbilirubinemia in healthy term and late-preterm Chinese infants. Eur J Pediatr. 2011;170:185–91. doi: 10.1007/s00431-010-1281-9. [DOI] [PubMed] [Google Scholar]

Articles from European Journal of Pediatrics are provided here courtesy of Springer

RESOURCES